Internal Medicine, Gastroenterology · Phila, PA
NPI
1568499184
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1101 Chestnut St
Phila, PA, 19107
Phone (215) 955-8900
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
430 services
Medicare patients, 2024
240
Average age 70
Drug cost, 2024
$7.0M
1,707 prescriptions
Company payments, 2025
$230
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia L Kozuch was code 99214 (office e&m - established), 83 times for 71 patients. In total Patricia L Kozuch billed 430 services in 34 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 83 | 71 | $69.52 | $5,770 |
| 45380 Lower GI Endoscopy - Other | Facility | 60 | 59 | $125.90 | $7,554 |
| 99213 Office E&M - Established | Facility | 51 | 49 | $47.80 | $2,438 |
| 43239 Upper GI Endoscopy | Facility | 40 | 40 | $65.19 | $2,608 |
| 99214 Office E&M - Established | Office | 29 | 24 | $99.20 | $2,877 |
| 99222 Hospital E&M - Initial | Facility | 28 | 28 | $105.22 | $2,946 |
| 99232 Hospital E&M - Subsequent | Facility | 25 | 15 | $60.82 | $1,520 |
| 45385 Colonoscopy - Lesion Removal | Facility | 20 | 20 | $213.75 | $4,275 |
| 99204 Office E&M - New | Facility | 11 | 11 | $107.75 | $1,185 |
By year: 2022 $31K for 339 services; 2023 $36K for 394 services; 2024 $38K for 430 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patricia L Kozuch prescribed most often to Medicare patients was Sodium Chloride (0.9 % Sodium Chloride), with 200 prescriptions and refills. In total Patricia L Kozuch wrote 1,707 Medicare prescriptions that cost $7.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sodium Chloride 0.9 % Sodium Chloride | 200 | 200 | Under 11 | $7,585 |
| Stelara Ustekinumab | 144 | 166 | 18 | $4.1M |
| Famotidine Generic | 128 | 270 | 39 | $1,615 |
| Mesalamine Generic | 127 | 259 | 30 | $87K |
| Omeprazole Generic | 104 | 260 | 28 | $1,573 |
| Famotidine Famotidine/Pf | 78 | 78 | Under 11 | $845 |
| Ondansetron Hcl Generic | 57 | 57 | Under 11 | $631 |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 54 | 60 | 11 | $2,522 |
| Linzess Linaclotide | 49 | 79 | Under 11 | $42K |
| Dicyclomine Hcl Generic | 47 | 69 | 16 | $789 |
| Colestipol Hcl Generic | 47 | 65 | Under 11 | $3,597 |
| Pantoprazole Sodium Generic | 42 | 110 | 15 | $539 |
| Ondansetron Odt Ondansetron | 41 | 41 | 14 | $1,448 |
| Skyrizi On-Body Risankizumab-Rzaa | 36 | 67 | Under 11 | $746K |
| Rinvoq Upadacitinib | 33 | 33 | Under 11 | $234K |
Brand drugs: - claims; generic drugs: 1,013 claims; opioid claims: 25.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patricia L Kozuch $230 ($230 in general payments such as food, travel and fees) from 3 companies. The largest payer was Janssen Scientific Affairs, LLC with $123.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.